Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Genix Pharmaceuticals Corporation (GENPF) operate in?
Genix Pharmaceuticals Corporation belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Genix Pharmaceuticals Corporation (GENPF) current stock price?
As of the latest data, Genix Pharmaceuticals Corporation stock price is $0.01, with a previous close of $0.01.
What is Genix Pharmaceuticals Corporation (GENPF) current market capitalization?
Genix Pharmaceuticals Corporation market cap is approximately 844.89 thousand.
What is Genix Pharmaceuticals Corporation (GENPF) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
What is Genix Pharmaceuticals Corporation (GENPF) EBITDA?
Genix Pharmaceuticals Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.54 thousand.
Does Genix Pharmaceuticals Corporation (GENPF) pay dividends?
No. Genix Pharmaceuticals Corporation does not pay a dividend.
What is Genix Pharmaceuticals Corporation (GENPF) beta (volatility) score?
Genix Pharmaceuticals Corporation has a beta of 0.430, indicating lower volatility than the overall market.
